In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Chlorhexamed Drug Master File in Korea (Chlorhexamed KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Chlorhexamed. The MFDS reviews the Chlorhexamed KDMF as part of the drug registration process and uses the information provided in the Chlorhexamed KDMF to evaluate the safety and efficacy of the drug.
After submitting a Chlorhexamed KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Chlorhexamed API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Chlorhexamed suppliers with KDMF on PharmaCompass.